Go to content

STAGING SITE Delivering the future of nucleic acid therapeutics.

    The Acuitas Advantage

    Acuitas is unique. We do not develop our own drugs. Our full commitment is to our partners and accelerating their path to the clinic and the market, enabled by our globally validated, best-in-class lipid nanoparticle (LNP) delivery systems.

    We invite you to discover the Acuitas advantage.

    Three people wearing white lab coats and yellow lanyards with ID badges stand behind a table covered with a green checkered tablecloth. They are posing for a photo in a booth with scientific posters displayed in the background.
    Partnerships

    We work with our partners to advance human health.

    At Acuitas, we operate on a strategic partnership model supported by innovative science, collaboration and dedication to partner success. Our team drives innovation to accelerate the development and success of our partners’ drug candidates from preclinical optimization through to clinical trials, regulatory approval and commercialization.

    Acuitas by the Numbers

    2

    Our LNP technology is used in two approved products currently on the market.

    26

    Twenty-six clinical trials have been initiated for partnered products enabled by Acuitas’ LNP in the last two years.

    40

    Our scientists contributed to more than 40 articles in peer-reviewed journals including Science, Nature and Cell in the last two years.

    LNP Technology

    We are the global leader in LNP delivery technology.

    Acuitas’ LNP technology is the culmination of more than four decades of research and development and has been clinically validated with two approved products, ONPATTRO® and COMIRNATY®. Learn more about our best-in-class and globally recognized LNP technology.

    Acuitas’ LNP technology is a paradigm shifter.

    Nucleic acid therapeutics have exceptional potential to address a wide variety of diseases, including traditionally challenging diseases such as cancer and genetic disease, but they need a safe and effective delivery technology. Acuitas’ LNP technology is versatile, allowing use over a broad range of medicines. Through ongoing research, we continue to explore new clinical applications for our technology.

    A man is seated at an office desk, focusing on a computer screen displaying data and graphs. He wears glasses and a smartwatch. The desk is cluttered with papers and office supplies. Various office equipment and boxes are visible in the background.
    Who We Are

    Inspired by science. Driven by purpose.

    We are on a mission to advance human health and to help people around the world to lead healthier lives. Our award-winning, experienced team work together at the cutting edge of science.

    To learn more about Acuitas, we invite you to visit the About Us page at the link below.

    A large group of people wearing matching blue and white shirts poses outdoors on a grassy area. Trees and a body of water are visible in the background under a clear blue sky. Some individuals are sitting in the front, while others are standing behind them.

    There’s no better place to work than here.

    At Acuitas, our collective aim is to improve human health through innovation. Realizing this ambitious goal requires a culture of mutual respect, openness, trust and accountability. We believe that excellence and innovation are achieved through a community of positive, caring and committed individuals. We are inspired by our work and our colleagues who want to make a lasting global impact through the groundbreaking potential of nucleic acid therapeutics.